Columbus Venture Partners successfully completes the sale of Syngoi Technologies to U.S. based Artis BioSolutions

by Columbus Venture Partners

Syngoi Technologies has developed in recent years its own enzymatic synthetic DNA platform, designed to address one of the key structural challenges in the gene and cell therapy industry: the efficien...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

The Food Sector: At the Heart of Europea...

by ONEtoONE Corporate Finance

During 2025 and the first quarter of 2026, the food sector stood out a...

Photos Stream